Clinical trial

Adherence to HIV Therapy in Heroin Addicts: Oral vs XR-NTX

NCT01101815

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Oral Naltrexone Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Naltrexone Implant Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Group Drug Counseling Manual Driven Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Adherence to HIV Therapy in Heroin Addicts: Oral vs XR-NTX

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-06-01

PhasePHASE2

Conditions

HIVunresolved

Substance Abuseverified · MONDO: substance abuse

HIV Infectionsunresolved

Interventions

Oral NaltrexoneDRUG

Naltrexone ImplantDRUG

Group Drug Counseling Manual DrivenBEHAVIORAL

Sponsors & collaborators

University of Pennsylvanialead sponsor

National Institute on Drug Abuse (NIDA)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01101815 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.